US Patent Issued to Dana-Farber Cancer Institute on June 30 for "Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 28" (Massachusetts Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,571, issued on June 30, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 28" was invented by Sara Buhrlage (Somerville, Mass.), Anthony Varca (Brookline, Mass.) and Bin Hu (Natick, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof and pharmaceutical composition comprising the compound of formula (I). The present composition also relates to methods treating a disease or disorder associated with ubiquitin-specific protease 28 ...